Phase II clinical study of DD-723 (perflubutane): dose–response study in patients with breast tumors - Concepedia

Concepedia

Publication | Closed Access

Phase II clinical study of DD-723 (perflubutane): dose–response study in patients with breast tumors

15

Citations

5

References

2012

Year

Yukio Miyamoto, Toshikazu Ito, Etsuo Takada, Kiyoka Omoto, Toshiko Hirai, Ryuzo Sekiguchi, Toshitaka Okuno, Shinsaku Kanazawa, Norio Nakata, Takao Igarashi

Journal of Medical Ultrasonics

Breast OncologyDose–response StudyMedicinePharmacologyBreast CancerCancer TreatmentOncologyRadiation OncologyBreast Tumors

References

	Year	Citations

Page 1

Page 1